Legal Opinion: BPCIA is Likely to Survive Latest ACA Challenge
November 11, 2020
Chad Landmon
The Center for Biosimilars
Axinn partner Chad Landmon co-authored The Center for Biosimilars article, "Legal Opinion: BPCIA is Likely to Survive Latest ACA Challenge."
Click here to access the article.